Proof-of-Concept for Liquid Biopsy Disease Monitoring of <i>MYC</i>-Amplified Group 3 Medulloblastoma by Droplet Digital PCR

Proof-of-Concept for Liquid Biopsy Disease Monitoring of <i>MYC</i>-Amplified Group 3 Medulloblastoma by Droplet Digital PCR

Background: Liquid biopsy diagnostic methods are an emerging complementary tool to imaging and pathology techniques across various cancer types. However, there is still no established method for the detection of molecular alterations and disease monitoring in MB, the most common malignant CNS tumor...

Full description

Bibliographic Details
Main Authors: Natalia Stepien, Daniel Senfter, Julia Furtner, Christine Haberler, Christian Dorfer, Thomas Czech, Daniela Lötsch-Gojo, Lisa Mayr, Cora Hedrich, Alicia Baumgartner, Maria Aliotti-Lippolis, Hannah Schned, Johannes Holler, Katharina Bruckner, Irene Slavc, Amedeo A. Azizi, Andreas Peyrl, Leonhard Müllauer, Sibylle Madlener, Johannes Gojo
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
liquid biopsy
droplet digital PCR
medulloblastoma
group 3
<i>MYC</i> amplification
minimal residual disease
Online Access:https://www.mdpi.com/2072-6694/15/9/2525

Internet

https://www.mdpi.com/2072-6694/15/9/2525

Similar Items